PSNL: Personalis Revenue Growth QoQ

Official company branding of Personalis, Inc. (PSNL)

Personalis, Inc. is diversifying its pool of external partners for clinical trials, as evidenced by the QoQ revenue growth rate. The value of 76.70 captures the current magnitude of the indicator. Business efficiency is based on the NeXt Personal platform, which reduces the cost of DNA analysis. Diagnostic speed is ensured by a streamlined express delivery system for transporting biomaterials to laboratories.

PSNL Personalis Corp Quarterly Revenue Growth Rate (07/04/2022 - 11/20/2026)

Summary analytical data breakdowns for Personalis Inc (PSNL)

- current quotes and average value forecast:
- market capitalization information:
- cash balance and cash flow data:
Fundamental company valuation:personalis.com (PSNL)
Manufactured products of Personalis

Three-month sales dynamics measure the rate of change in incoming cash flow, allowing for an assessment of capital vulnerability to market shocks and declining demand. Amid intense competition in the genomic analysis sector, the quarterly revenue growth of Personalis, Inc. (PSNL) serves as an indicator of the company's ability to maintain market share in the face of cheaper sequencing technologies, where any negative trend could trigger a mass sell-off of shares.

Competitors of Personalis, Inc.

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Ascentage Pharma Group International (AAPG)|Revenue Growth QoQ CG Oncology, Inc.|Quarterly Revenue Growth Rate UroGen Pharma Corp URGN|Quarterly Revenue Growth BCAX|Quarterly Revenue Growth Erasca (ERAS)|Quarterly Revenue Growth DCTH (Delcath Systems)|Quarterly Revenue Increase YMAB|AURA - Revenue Growth QoQ|candeltx.com - Sales Change QoQ|ARAY: Quarterly Revenue Growth|Revenue Dynamics QoQ SLS (SELLAS Life Sciences Group, Inc.)|ACTU (Actuate Therapeutics) - Quarterly Revenue Growth|Quarterly Sales Growth Citius Oncology Inc. (CTOR)|Revenue Growth QoQ TuHURA (HURA)|TARA - Quarterly Revenue Growth Rate|Quarterly Revenue Growth FATE (Fate Therapeutics Inc)|Aadi Bioscience Inc (WHWK) - Quarterly Revenue Growth Rate|TScan - Quarterly Revenue Growth|Champions Oncology, Inc. (CSBR) - Quarterly Sales Growth|XBIT (XBiotech Inc.) - Quarterly Sales Growth|CEL-SCI Corporation (CVM) - Quarterly Revenue Growth|Revenue Growth QoQ OS Therapies|RADX: Quarterly Revenue Increase|Revenue Growth QoQ artivabio.com (ARTV)|Quarterly Sales Growth Rate Adlai Nortye|Quarterly Revenue Growth VERU (Veru Corporation)|Sales Change QoQ TPST (Tempest Tx)|XLO: Quarterly Sales Growth|renovarobio.com (RENB) - Quarterly Sales Growth|Mural Bio (MURA) - Revenue Growth QoQ|Kairos Pharma Inc (KAPA) - Quarterly Revenue Growth|Quarterly Sales Growth OKUR|CytoMed Therapeutics (GDTC) - Quarterly Sales Growth Rate|Quarterly Sales Growth CRIS (Curis Inc.)|Quarterly Revenue Growth Apollomics Inc. (APLM)|Revenue Growth QoQ Tharimmune Corp THAR|Advanced Biomed Corp - Revenue Growth QoQ|GNPX: Quarterly Sales Growth|Calidi Biotherapeutics, Inc. (CLDI) - Quarterly Sales Growth|SBFM: Quarterly Revenue Growth|Quarterly Sales Growth Xenetic Biosciences Inc.|Revenue Growth QoQ Salarius Pharmaceuticals Inc|PPBT: Quarterly Revenue Increase|Quarterly Revenue Growth AONC|BGNE (BeOne Medicines) - Quarterly Revenue Increase|Checkpoint Therapeutics, Inc - Quarterly Sales Growth|elevationoncology.com (ELEV) - Quarterly Revenue Growth Rate|iCAD Inc. - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Ikena Oncology|NTBL: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)